Bakhu Holdings Corp

Healthcare US BKUH

NoneUSD
0.00(0%)

Last update at 2026-06-24T15:04:05.852881Z

Day Range

LowHigh

52 Week Range

0.0010.02

LowHigh

Fundamentals

Previous Close 0.001
Market Cap6.03M
VolumeNone
P/E Ratio-
Dividend Yield-%
EBITDA-3.31949M
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-0.01

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Income before tax	-10.30545M	-5.15574M	-5.15574M	-1.10667M	-10.65189M
Minority interest	-	-	-	-	-
Net income	-10.30545M	-5.22339M	-5.15574M	-1.12348M	-10.65256M
Selling general administrative	8.93M	5.09M	5.09M	1.09M	10.65M
Selling and marketing expenses	-	-	-	-	-
Gross profit	-0.13367M	-	-	-	-
Reconciled depreciation	0.13M	0.08M	-	-	-
Ebit	-10.11156M	-18.04317M	-6.82236M	-1.08985M	-10.65123M
Ebitda	-9.97789M	-5.08809M	-5.08809M	-1.08985M	-10.65123M
Depreciation and amortization	0.13M	0.08M	-	-	-
Non operating income net other	-	-2.87177M	-	-	-
Operating income	-10.04581M	-5.08809M	-5.08809M	-1.08985M	-10.65123M
Other operating expenses	10.05M	5.09M	-	1.09M	10.65M
Interest expense	0.19M	0.07M	0.07M	0.02M	0.00067M
Tax provision	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Interest income	-	-	-	-	-
Net interest income	-0.19389M	-0.13693M	-0.06765M	-0.01682M	-0.00067M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	0.19M	0.07M	-	0.02M	0.00067M
Total revenue	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	9.91M	5.09M	5.09M	1.09M	10.65M
Cost of revenue	0.13M	-	-	-	-
Total other income expense net	-0.25964M	-0.06765M	-	-0.01682M	-0.00067M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-10.30545M	-20.91494M	-5.15574M	-1.10667M	-10.65189M
Net income applicable to common shares	-	-20.91494M	-6.89001M	-1.10667M	-10.65189M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Total assets	0.47M	0.05M	0.05M	0.02M	0.00163M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	-
Total liab	9.80M	2.51M	2.51M	0.44M	0.15M
Total stockholder equity	-9.32582M	-2.46542M	-2.46542M	-0.41966M	-0.15109M
Deferred long term liab	-	-	-	-	-
Other current liab	0.41M	0.08M	-	0.01M	-
Common stock	0.30M	0.30M	0.30M	0.30M	0.29M
Capital stock	0.30M	0.30M	0.30M	0.30M	0.29M
Retained earnings	-47.47949M	-20.88042M	-22.61469M	-15.72468M	-14.61801M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	0.00000M	-	-	-	-
Cash	0.00310M	0.05M	0.05M	0.02M	0.00163M
Cash and equivalents	-	-	-	-	-
Total current liabilities	9.80M	2.51M	2.51M	0.44M	0.15M
Current deferred revenue	-2.63928M	-	-	-	-
Net debt	6.74M	1.88M	1.88M	0.35M	0.15M
Short term debt	6.74M	1.93M	-	0.37M	0.15M
Short long term debt	6.74M	6.37M	1.93M	0.37M	0.15M
Short long term debt total	6.74M	1.93M	-	0.37M	0.15M
Other stockholder equity	37.85M	18.11M	-	15.00M	14.18M
Property plant equipment	-	0.69M	-	-	-
Total current assets	0.00310M	0.05M	0.05M	0.02M	0.00163M
Long term investments	-	-	-	-	-
Net tangible assets	-	-7.15752M	-2.46542M	-0.41966M	-0.15109M
Short term investments	-	-	-	-	-
Net receivables	-	-	-	-	-
Long term debt	-	-	-	-	-
Inventory	-	-	-	-	-
Accounts payable	2.64M	0.50M	0.50M	0.05M	0.00521M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	0.30M	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-43.52963M	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	0.00000M	0.69M	-	-	0.00000M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.47M	0.69M	0.00000M	0.00000M	0.00000M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-07-31	2022-07-31	2021-07-31	2020-07-31	2019-07-31
Investments	0.02M	0.00000M	0.00000M	0.00000M	-
Change to liabilities	-	0.90M	0.45M	0.05M	-0.00779M
Total cashflows from investing activities	0.02M	-	-	-	-
Net borrowings	0.37M	0.94M	1.56M	0.23M	0.15M
Total cash from financing activities	0.40M	1.82M	1.82M	0.51M	0.15M
Change to operating activities	-	0.14M	0.07M	0.01M	0.00067M
Net income	-10.30545M	-5.15574M	-6.89001M	-1.10667M	-10.65189M
Change in cash	-0.00935M	0.03M	0.03M	0.02M	-0.01150M
Begin period cash flow	0.01M	0.02M	0.02M	0.00163M	0.01M
End period cash flow	0.00310M	0.05M	0.05M	0.02M	0.00163M
Total cash from operating activities	-0.43167M	-1.79433M	-1.79433M	-0.49364M	-0.15902M
Issuance of capital stock	0.03M	1.61M	0.27M	0.28M	0.00000M
Depreciation	0.13M	0.08M	0.08M	0.08M	0.08M
Other cashflows from investing activities	0.02M	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	-	-	-	-
Change to account receivables	-	-	-	-	-
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	0.02M	1.72M	-	0.25M	0.14M
Change to netincome	-	17.35M	4.58M	0.55M	10.50M
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-0.03448M	-	-	-
Change in working capital	1.57M	0.52M	0.52M	0.06M	-0.00712M
Stock based compensation	8.11M	2.84M	2.84M	0.55M	10.50M
Other non cash items	1.44M	2.73M	-	-	-
Free cash flow	-0.43167M	-1.79433M	-1.79433M	-0.49364M	-0.15902M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to EBITDA (x)
BKUH Bakhu Holdings Corp	- -%	-	-	-	-	-	-15.7634
ZTS Zoetis Inc	1.46 1.89%	78.30	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	0.83 2.69%	31.72	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	155.71	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	1.58 3.64%	45.00	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Bakhu Holdings, Corp. produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use. The company was formerly known as Planet Resources, Corp. and changed its name to Bakhu Holdings, Corp. in May 2009. Bakhu Holdings, Corp. was incorporated in 2008 and is headquartered in Long Beach, California.

Bakhu Holdings Corp

One World Trade Center, Long Beach, CA, United States, 90831

858 682 2528
https://www.bakhuholdings.com
Employees : 2

Key Executives

Name	Title	Year Born
Mr. Evripides Drakos	CEO & Chairman of Directors	1974
Mr. Juan Carlos Garcia La Sienra Garcia	Chief Financial Officer	1973
Dr. Peter Whitton	Head of Science & Director	1968
Dr. Michael R. Hawthorne Ph.D.	Deputy Chief Exec. Officer	1975
Mr. Aristotle Popolizio	Exec. VP, Sec., & Director	1996
Mr. Juan Carlos Garcia La Sienra Garcia	Chief Financial & Accounting Officer	1973
Mr. Aristotle Popolizio	Executive VP, Secretary, & Director	1996
Dr. Teddy C. Scott J.D., Ph.D.	President & CEO	1967

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.